Coumarins Derivatives as Dual Inhibitors of Acetylcholinesterase and Monoamine Oxidase
Journal of Medicinal Chemistry2001Vol. 44(19), pp. 3195–3198
Citations Over TimeTop 12% of 2001 papers
Corinne Brühlmann, Frédéric Ooms, Pierre‐Alain Carrupt, Bernard Testa, Marco Catto, Francesco Leonetti, Cosimo Altomare, Angelo Carotti
Abstract
A set of 17 coumarin and 2 chromone derivatives with known inhibitory activity toward monoamine oxidase (MAO) A and B were tested as acetylcholinesterase (AChE) inhibitors. All compounds inhibited AChE with values in the micromolar range (3-100 microM). A kinetic study showed that most compounds acted as noncompetitive AChE inhibitors. This finding may be of interest in the context of Alzheimer's disease because recent observations suggest that MAO and AChE inhibition might decrease beta-amyloid deposition.
Related Papers
- → Design, synthesis and evaluation of novel tacrine–coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease(2013)155 cited
- → Synthesis and biological evaluation of functionalized coumarins as acetylcholinesterase inhibitors(2005)91 cited
- → Selected C7-substituted chromone derivatives as monoamine oxidase inhibitors(2012)58 cited
- → Discovery of Reversible Selective Monoamine Oxidase B Inhibitors With anti-acetylcholinesterase Activity Derived From 4-oxo-N-4-diphenyl Butanamides(2023)5 cited
- → Postnatal development of cholinesterase, acetylcholinesterase, aromatic -amino acid decarboxylase and monoamine oxidase in C57BL/6 and DBA/2 mice(1968)10 cited